Short VIX Short-Term Fut ETF Proshares (SVXY) 65.14

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Short VIX Short-Term Fut ETF Proshares (SVXY) 65.14 $SVXY

What To Do With Quiet Markets?
Adam Grimes - at Seeking Alpha - Wed Mar 04, 1:47PM CST
Just a high level perspective on what we have going on in a few major markets this week. In general, most markets are in some kind of volatility compression . Volatility compression is a term that basically means current volatility conditions are...
TVIX: 2.01 (-0.02), SPY: 210.23 (-0.89), QQQ: 108.45 (-0.42), VXX: 27.22 (-0.06), IVOP: 38.01 (+0.13), DIA: 180.78 (-1.09), UVXY: 17.32 (-0.04), VIIX: 36.82 (-0.06), XXV: 38.28 (+0.01), VIXY: 18.08 (-0.05), SVXY: 65.14 (+0.16), XIV: 33.17 (+0.08)

Equity Volatility - Going Higher
Macronomics - Seeking Alpha - Mon Mar 02, 9:12AM CST
"When dealing with people, remember you are not dealing with creatures of logic, but creatures of emotion." - Dale Carnegie, American writer Please find below a great guest post from our good friends at Rcube Global Asset Management ...
TVIZ: 19.42 (+0.11), TVIX: 2.01 (-0.02), VIXM: 60.28 (+0.10), XVIX: 16.23 (+0.01), VXX: 27.22 (-0.06), IVOP: 38.01 (+0.13), UVXY: 17.32 (-0.04), VXZ: 12.35 (-0.01), CVOL: 0.83 (unch), XIV: 33.17 (+0.08), SVXY: 65.14 (+0.16), EEM: 39.93 (-0.44), XVZ: 28.19 (+0.05), ZIV: 42.97 (-0.06), VIIX: 36.82 (-0.06), VIIZ: 17.32 (+0.07), XXV: 38.28 (+0.01), VIXY: 18.08 (-0.05)

The VIX: What It Is, What It Isn't, What To Do About It Now
Peter F. Way, CFA - at Seeking Alpha - Mon Feb 23, 4:17PM CST

VIXM: 60.28 (+0.10), VXX: 27.22 (-0.06), UVXY: 17.32 (-0.04), VIIX: 36.82 (-0.06), SVXY: 65.14 (+0.16), VIXY: 18.08 (-0.05)

U.S. Equity Volatility Is 'Back To Average'
ValueWalk - at Seeking Alpha - Wed Feb 11, 3:30AM CST
By Michael Ide Morgan Stanley says that it's understandable that volatility us up for most asset classes, but sees room for US equity volatility to fall again. Volatility is up across the board, in some cases from historic lows to recent highs,...
TVIX: 2.01 (-0.02), VXX: 27.22 (-0.06), IVOP: 38.01 (+0.13), UVXY: 17.32 (-0.04), VIIX: 36.82 (-0.06), XXV: 38.28 (+0.01), VIXY: 18.08 (-0.05), SVXY: 65.14 (+0.16), XIV: 33.17 (+0.08)

Short-Term VIX Futures Products Should Be Avoided Until Better Opportunities Arise
Nathan Buehler - at Seeking Alpha - Mon Feb 09, 2:03PM CST

VXX: 27.22 (-0.06), UVXY: 17.32 (-0.04), XIV: 33.17 (+0.08), SVXY: 65.14 (+0.16)

The Year In VIX And Volatility - 2014
Bill Luby - at Seeking Alpha - Mon Jan 26, 11:05PM CST
This is the seventh year in a row I have offered a retrospective look at the year in VIX and Volatility, which is my attempt to cram some of the highlights of the year in volatility onto one graphic with a (somewhat) manageable number of annotations....
TVIZ: 19.42 (+0.11), TVIX: 2.01 (-0.02), XVZ: 28.19 (+0.05), VIXM: 60.28 (+0.10), XVIX: 16.23 (+0.01), ZIV: 42.97 (-0.06), VXX: 27.22 (-0.06), IVOP: 38.01 (+0.13), UVXY: 17.32 (-0.04), VIIX: 36.82 (-0.06), CVOL: 0.83 (unch), VXZ: 12.35 (-0.01), VIIZ: 17.32 (+0.07), XXV: 38.28 (+0.01), VIXY: 18.08 (-0.05), SVXY: 65.14 (+0.16), XIV: 33.17 (+0.08)

One Reason Why The New VIX Calculation Is Better
Vance Harwood - at Seeking Alpha - Tue Jan 13, 5:02PM CST
The CBOE changed the way the VIX® was calculated on October 6th, 2014- asserting the change would provide a more accurate assessment of expected volatility. The new process does look better to me, but I've been surprised that the new VIX and the...
TVIZ: 19.42 (+0.11), TVIX: 2.01 (-0.02), XVZ: 28.19 (+0.05), VIXM: 60.28 (+0.10), XVIX: 16.23 (+0.01), ZIV: 42.97 (-0.06), VXX: 27.22 (-0.06), IVOP: 38.01 (+0.13), UVXY: 17.32 (-0.04), VIIX: 36.82 (-0.06), CVOL: 0.83 (unch), VXZ: 12.35 (-0.01), VIIZ: 17.32 (+0.07), XXV: 38.28 (+0.01), VIXY: 18.08 (-0.05), SVXY: 65.14 (+0.16), XIV: 33.17 (+0.08)

The Current VIX Landscape Deserves Risk Assessments
Nathan Buehler - at Seeking Alpha - Wed Jan 07, 1:08AM CST

UVXY: 17.32 (-0.04), SVXY: 65.14 (+0.16)

2014's Santa Rally Delivers Gains As Expected And Ends With Two Historic Moves
Dr. Duru - at Seeking Alpha - Sun Jan 04, 9:33AM CST

SFLA: 180.57 (unch), RWL: 41.66 (-0.18), RSP: 81.86 (-0.39), SH: 21.22 (+0.10), VXX: 27.22 (-0.06), SSO: 133.54 (-1.08), SPUU: 145.93 (-1.18), IVV: 211.71 (-0.89), SPLX: 31.94 (-0.75), SVXY: 65.14 (+0.16), SPXU: 34.90 (+0.46), VOO: 192.83 (-0.81), UPRO: 140.03 (-1.87), EPS: 72.96 (-0.24), SPY: 210.23 (-0.89), SDS: 20.86 (+0.17), SPXL: 92.78 (-1.16)

My Volatility Outlook For 2015
Josh Arnold - at Seeking Alpha - Sun Dec 28, 1:20AM CST

VIXM: 60.28 (+0.10), VXX: 27.22 (-0.06), VIXH: 26.29 (unch), VIXY: 18.08 (-0.05), SVXY: 65.14 (+0.16)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Dec 26, 4:35PM CST

TVIX: 2.01 (-0.02), IHT: 2.90 (+0.02), BLCM: 24.32 (+0.92), VXX: 27.22 (-0.06), JNUG: 25.00 (-2.00), UVXY: 17.32 (-0.04), RLGY: 46.42 (+0.19), JD: 27.72 (+0.19), JDST: 10.28 (+0.71), SVXY: 65.14 (+0.16)

The Most Consistent Risk/Reward Speculation That I Have Ever Found
Scott Brown - Seeking Alpha - Fri Dec 19, 1:54PM CST
Everyone loves a good speculation. The problem is that every good speculation has a good bit of risk associated with it, thus the reason why it is considered speculation and not an investment. I've heard all sorts of market "experts" that...
EDZ: 34.26 (+1.00), TZA: 10.85 (+0.10), JNUG: 25.00 (-2.00), UVXY: 17.32 (-0.04), TNA: 85.29 (-0.80), DUST: 15.62 (+0.75), EDC: 23.65 (-0.77), NUGT: 13.06 (-0.73), SVXY: 65.14 (+0.16), JDST: 10.28 (+0.71)

Today: Top Of The VIX? Bottom For SVXY?
Peter F. Way, CFA - at Seeking Alpha - Wed Dec 17, 2:54PM CST

SVXY: 65.14 (+0.16)

Current Events Provide A VIX Opportunity
Nathan Buehler - Seeking Alpha - Mon Dec 15, 10:35AM CST
Hello everyone! I am happy to be back writing. During the school year, I get very bogged down from August to November. Luckily, academics are going well and things have begun to taper off towards Christmas. Next semester, I am teaching day and night...
UVXY: 17.32 (-0.04), SVXY: 65.14 (+0.16)

The Volatility Battleground
Markit - Seeking Alpha - Mon Dec 15, 6:26AM CST
Volatility has declined since the spike in October, but developments in Greece and oil price effects have disturbed the calm conditions. Volatility was the name of the game earlier in the first quarter as credit was swept up in the maelstrom...
TVIX: 2.01 (-0.02), VXX: 27.22 (-0.06), IVOP: 38.01 (+0.13), GREK: 12.42 (-0.13), UVXY: 17.32 (-0.04), ACWV: 71.55 (-0.19), VIIX: 36.82 (-0.06), XXV: 38.28 (+0.01), VIXY: 18.08 (-0.05), SVXY: 65.14 (+0.16), XIV: 33.17 (+0.08)

The Best Offense Is A Good Defense: Profiting From Hedging
AllAboutAlpha - Seeking Alpha - Thu Dec 04, 4:25PM CST
This time of year one often encounters certain football-fans' truisms. Sometimes one is told "the best defense is a good offense." At other times, "the best offense is a good defense." At yet other times, "it's all in the...
TVIX: 2.01 (-0.02), VXX: 27.22 (-0.06), IVOP: 38.01 (+0.13), UVXY: 17.32 (-0.04), VIIX: 36.82 (-0.06), XXV: 38.28 (+0.01), VIXY: 18.08 (-0.05), SVXY: 65.14 (+0.16), XIV: 33.17 (+0.08)

Short Volatility: A Great Long-Term Investment As Always
Thomas Novak - at Seeking Alpha - Thu Dec 04, 9:51AM CST

TVIX: 2.01 (-0.02), VXX: 27.22 (-0.06), XIV: 33.17 (+0.08), SVXY: 65.14 (+0.16)

The Curious Case Of Elevated Volatility (Weight Of Evidence, Part 2 Of 7)
360 Investment Research - at Seeking Alpha - Tue Nov 18, 2:33PM CST
"Fear tends to manifest itself much quicker than greed, so volatile markets tend to be on the downside. In up markets, volatility tends to gradually decline." ~ Philip Roth The CBOE Volatility Index is often referred to as the FEAR Index....
TVIX: 2.01 (-0.02), VXX: 27.22 (-0.06), IVOP: 38.01 (+0.13), UVXY: 17.32 (-0.04), VIIX: 36.82 (-0.06), XXV: 38.28 (+0.01), VIXY: 18.08 (-0.05), SVXY: 65.14 (+0.16), XIV: 33.17 (+0.08)

Why I'm Done Shorting Volatility For Now
Josh Arnold - at Seeking Alpha - Tue Nov 18, 3:21AM CST

VXX: 27.22 (-0.06), SVXY: 65.14 (+0.16)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

U Power Limited Advances Electric Vehicle Solutions in Europe

Updated Category News Views 239

U Power Limited Expands Its European Reach U Power Limited (Nasdaq: UCAR) is making significant strides in the electric vehicle (EV) landscape. The company, known for its innovative battery-swapping technology, has announced an exciting joint venture that enhances their presence in the European market. This strategic move is expected to reshape how electric mobility is...

Continue Reading
UKG Stands Out as a Top Leader in Workforce Management Solutions

Updated Category News Views 163

UKG Secures Top Spot in Workforce Management UKG, a leading provider in HR, payroll, workforce management, and cultural solutions, has recently earned recognition for its exceptional contributions to the workforce management field. The company has been named a Leader in the NelsonHall New World Workforce Management 2024 evaluation, showcasing its strong performance across...

Continue Reading
Prominent Movers in Today's Market: Micron, Accenture Rise

Updated Category News Views 141

As the trading day unfolds, the US stock market is witnessing a shift, with several companies experiencing significant movements in their stock prices. Recent trends show that investors are closely monitoring the market after a minor disruption in gains. Micron's Robust Performance Micron Technology (NASDAQ: MU) has captured the spotlight today, with shares surging by an...

Continue Reading
Celebrate 1.5 Years of Obey Me! Nightbringer with Exciting Events

Updated Category News Views 85

Celebrating 1.5 Years of Obey Me! Nightbringer Obey Me! Nightbringer is reaching a significant milestone, celebrating its 1.5-year anniversary. This beloved mobile game from NTT Solmare has captured the hearts of players around the globe, and to acknowledge this momentous occasion, the developers are rolling out a variety of exciting events. Four Exciting Events for...

Continue Reading
Celebrating Innovation: 2026 sofi™ Awards Winners Unveiled

Updated Category News Views 219

Celebrating Culinary Excellence: The 2026 sofi™ Awards NEW YORK — The Specialty Food Association (SFA) revealed the much-anticipated results of the 2026 sofi™ Awards at the Winter FancyFaire event. This celebrated gathering brought together industry leaders, chefs, makers, and buyers to applaud the finest in specialty food and beverage innovation. A Night of...

Continue Reading